Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 5—May 2010
Letter

Cross-Reactive Antibodies to Pandemic (H1N1) 2009 Virus, Singapore

Julian W. TangComments to Author , Paul A. Tambyah, Annelies Wilder-Smith, Kim-Yoong Puong, Robert Shaw, Ian G. Barr, and Kwai-Peng Chan
Author affiliations: National University Hospital, Singapore (J.W. Tang); National University of Singapore, Singapore (P.A. Tambyah, A. Wilder-Smith); Singapore General Hospital, Singapore (K.-Y. Puong, K.-P. Chan); World Health Organization Laboratory for Influenza Reference and Research, Melbourne, Victoria, Australia (R. Shaw, I. Barr)

Main Article

Table

Cross-reactive antibody titers to pandemic (H1N1) 2009 and seasonal influenza viruses for 50 persons, Singapore, May–October 2009*

Patient age, y/sex Laboratory 1 (Singapore General Hospital)
 Laboratory 2 (WHO, Melbourne)+
A/Auckland/1/2009
 A/Brisbane/59/2007
 A/Auckland/1/2009
 A/Brisbane/59/2007
HI† MN HI† MN HI‡ HI† HI‡
45/F <10 <10 <10 <10 <10 <10 <10
52/F <10 10 10 10 <10 10 <10
52/F <10 <10 10 <10 <10 <10 <10
52/F <10 <10 10 <10 <10 <10 <10
53/M <10 <10 10 <10 <10 <10 <10
53/F <10 <10 20 40 <10 <10 40
53/F <10 <10 160 80 <10 <10 160
53/M <10 <10 10 <10 <10 <10 <10
53/F <10 <10 160 320 <10 <10 160
53/F <10 <10 10 <10 <10 <10 <10
54/F <10 <10 10 <10 <10 <10 <10
54/M 10 <10 10 <10 <10 20 <10
55/F <10 <10 10 <10 <10 10 <10
55/F <10 <10 160 40 <10 <10 160
55/M <10 <10 10 <10 <10 <10 <10
56/F <10 <10 20 10 <10 <10 10
56/F <10 <10 80 80 <10 20 40
56/F <10 10 10 40 <10 <10 10
56/F <10 <10 10 <10 <10 <10 <10
57/M 10 20 40 40 20 20 <10
58/M <10 <10 20 20 <10 10 20
58/F <10 <10 40 20 <10 <10 80
59/M <10 <10 10 <10 <10 <10 <10
59/M <10 <10 20 20 20 20 10
59/F <10 <10 40 40 <10 <10 40
60/M <10 <10 80 40 <10 <10 80
60/M <10 <10 20 10 <10 <10 20
60/F 10 <10 10 <10 NR <10 <10
61/F 10 <10 10 <10 <10 10 <10
61/M 10 <10 160 160 <10 <10 320
61/M <10 <10 <10 <10 <10 <10 <10
61/F <10 <10 10 <10 <10 <10 <10
62/F <10 20 10 20 NR NR NR
62/F 10 10 80 20 <10 <10 40
62/F <10 <10 20 10 <10 20 40
62/F <10 <10 80 40 <10 <10 80
63/M <10 <10 80 40 <10 <10 80
63/F <10 <10 10 <10 <10 <10 <10
63/M <10 <10 40 20 <10 <10 20
63/M <10 <10 40 80 <10 <10 20
64/F 10 <10 20 10 <10 10 10
65/F 10 <10 10 <10 <10 20 <10
66/M <10 <10 <10 <10 <10 <10 <10
68/M <10 <10 40 80 <10 <10 40
71/F 10 10 10 20 <10 <10 <10
72/F <10 20 10 20 10 10 <10
75/M <10 <10 10 10 <10 20 <10
76/M <10 <10 40 20 <10 <10 40
78/F <10 10 10 20 <10 <10 <10
82/F 10 10 20 10 <10 20 <10

*WHO, World Health Organization; HI, hemagglutination inhibition; MN, microneutralization; NR, no results (because of insufficient serum).
†Tested with guinea pig erythrocytes.
‡Tested with turkey erythrocytes.

Main Article

Page created: December 23, 2010
Page updated: December 23, 2010
Page reviewed: December 23, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external